{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:18:15Z","timestamp":1794345495700,"version":"4.9.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Glioblastoma (GBM), a World Health Organization (WHO) grade IV glioma, is one of the most lethal brain tumors, with a poor prognosis and limited treatment options. Temozolomide (TMZ), a first-line chemotherapeutic agent, often proves ineffective due to resistance and toxicity associated with overexpressed <jats:italic>O<\/jats:italic>\n            <jats:sup>6<\/jats:sup>-methylguanine-DNA-methyltransferase (MGMT). In this study, we identified ubiquitin-specific protease 7 (USP7) as a nuclear regulator of MGMT stability and TMZ resistance. USP7 binds directly to MGMT via its UBL domain, counteracts K48-linked ubiquitin chains, and prevents MGMT proteasomal degradation. This functional relationship is further supported by their nuclear colocalization. Strikingly, this study, together with previous findings, establishes USP7 as a key integrator of all three major alkylation repair pathways through its role in stabilizing alkylation repair proteins. USP7 stabilizes MGMT through a dual mechanism, thereby modulating the direct reversal repair pathway. Inhibition or knockdown of USP7 reduces MGMT levels, as well as those of XPC, ALKBH2, and ALKBH3, impairs DNA repair capacity, and sensitizes GBM cells to TMZ, enabling effective treatment with reduced TMZ dosages. Clinically, tissue microarray analyses reveal that USP7 and MGMT co-overexpression in GBM correlates with poor patient survival. Collectively, our results uncover a new and direct role for USP7 in MGMT-mediated direct reversal repair and TMZ resistance, positioning USP7 as a distinctive integrator of alkylation repair pathways. Targeting USP7 provides mechanistic insights into regulating diverse alkylation repair pathways and offers a strategy to enhance the efficacy of combination chemotherapies, including TMZ and other alkylating agents, by modulating distinct repair mechanisms in GBM.<\/jats:p>","DOI":"10.1038\/s41419-025-07969-3","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T10:36:34Z","timestamp":1755686194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["USP7 promotes temozolomide resistance by stabilizing MGMT in glioblastoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Jiabing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuming","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9856-3917","authenticated-orcid":false,"given":"Yu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"7969_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1383-5742(00)00017-X","volume":"462","author":"AE Pegg","year":"2000","unstructured":"Pegg AE. Repair of O(6)-alkylguanine by alkyltransferases. Mutat Res. 2000;462:83\u2013100.","journal-title":"Mutat Res"},{"key":"7969_CR2","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3390\/ph7070797","volume":"7","author":"CL Moody","year":"2014","unstructured":"Moody CL, Wheelhouse RT. The medicinal chemistry of imidazotetrazine prodrugs. Pharmaceuticals (Basel). 2014;7:797\u2013838.","journal-title":"Pharmaceuticals (Basel)"},{"key":"7969_CR3","first-page":"513","volume":"19","author":"R Ortiz","year":"2021","unstructured":"Ortiz R, Perazzoli G, Cabeza L, Jim\u00e9nez-Luna C, Luque R, Prados J, et al. Temozolomide: an updated overview of resistance mechanisms, nanotechnology advances and clinical applications. Curr Neuropharmacol. 2021;19:513\u201337.","journal-title":"Curr Neuropharmacol"},{"key":"7969_CR4","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.2147\/DDDT.S306602","volume":"15","author":"X Su","year":"2021","unstructured":"Su X, Chen S, Lu H, Li H, Qin C. Study on the inhibitory effect of curcumin on GBM and its potential mechanism. Drug Des Devel Ther. 2021;15:2769\u201381.","journal-title":"Drug Des Devel Ther"},{"key":"7969_CR5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3390\/cancers14030485","volume":"14","author":"A Sumiyoshi","year":"2022","unstructured":"Sumiyoshi A, Shibata S, Zhelev Z, Miller T, Lazarova D, Aoki I, et al. Targeting glioblastoma via selective alteration of mitochondrial redox state. Cancers (Basel). 2022;14:485.","journal-title":"Cancers (Basel)"},{"key":"7969_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12939-022-01704-6","volume":"21","author":"LA Salha","year":"2022","unstructured":"Salha LA, Reis FC, Gon\u00e7alves RM, Lima J, Salha NA, Pinto RP, et al. Judicialization of health: profile of demands for oncological medicines in a state in the central region of Brazil. Int J Equity Health. 2022;21:112.","journal-title":"Int J Equity Health"},{"key":"7969_CR7","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.tibs.2016.10.001","volume":"42","author":"JM Soll","year":"2017","unstructured":"Soll JM, Sobol RW, Mosammaparast N. Regulation of DNA alkylation damage repair: lessons and therapeutic opportunities. Trends Biochem Sci. 2017;42:206\u201318.","journal-title":"Trends Biochem Sci"},{"key":"7969_CR8","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1200\/JCO.2002.06.110","volume":"20","author":"SL Gerson","year":"2002","unstructured":"Gerson SL. Clinical relevance of MGMT in the treatment of cancer. J Clin Oncol. 2002;20:2388\u201399.","journal-title":"J Clin Oncol"},{"key":"7969_CR9","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa043331","volume":"352","author":"ME Hegi","year":"2005","unstructured":"Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005;352:997\u20131003.","journal-title":"N Engl J Med"},{"key":"7969_CR10","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1200\/JCO.1998.16.12.3851","volume":"16","author":"HS Friedman","year":"1998","unstructured":"Friedman HS, McLendon RE, Kerby T, Dugan M, Bigner SH, Henry AJ, et al. DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma. J Clin Oncol. 1998;16:3851\u20137.","journal-title":"J Clin Oncol"},{"key":"7969_CR11","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2174\/1389557515666150722101046","volume":"16","author":"KS Srivenugopal","year":"2016","unstructured":"Srivenugopal KS, Rawat A, Niture SK, Paranjpe A, Velu C, Venugopal SN, et al. Posttranslational regulation of O6-methylguanineDNA methyltransferase (MGMT) and new opportunities for treatment of brain cancers. Mini Rev Med Chem. 2016;16:455\u201364.","journal-title":"Mini Rev Med Chem"},{"key":"7969_CR12","first-page":"282","volume":"60","author":"KS Srivenugopal","year":"2000","unstructured":"Srivenugopal KS, Mullapudi SRS, Shou J, Hazra TK, Ali-Osman F. Protein phosphorylation is a regulatory mechanism for O6-alkylguanine-DNA alkyltransferase in human brain tumor cells. Cancer Res. 2000;60:282\u20137.","journal-title":"Cancer Res"},{"key":"7969_CR13","first-page":"137","volume":"64","author":"CS Velu","year":"2004","unstructured":"Velu CS, Niture SK, Bailey N, Srivenugopal KS. Posttranslational regulation of human MGMT by sumoylation in brain tumor cells. Cancer Res. 2004;64:137.","journal-title":"Cancer Res"},{"key":"7969_CR14","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2174\/1389557515666150722101046","volume":"16","author":"KS Srivenugopal","year":"2016","unstructured":"Srivenugopal KS, Rawat A, Niture SK, Paranjpe A, Velu C, Venugopal SN, et al. Posttranslational regulation of O(6)-methylguanine-DNA methyltransferase (MGMT) and new opportunities for treatment of brain cancers. Mini Rev Med Chem. 2016;16:455\u201364.","journal-title":"Mini Rev Med Chem"},{"key":"7969_CR15","doi-asserted-by":"publisher","first-page":"5940","DOI":"10.1038\/sj.onc.1205762","volume":"21","author":"KS Srivenugopal","year":"2002","unstructured":"Srivenugopal KS, Ali-Osman F. The DNA repair protein, O(6)-methylguanine-DNA methyltransferase is a proteolytic target for the E6 human papillomavirus oncoprotein. Oncogene. 2002;21:5940\u20135.","journal-title":"Oncogene"},{"key":"7969_CR16","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.bcp.2018.10.029","volume":"158","author":"SH Hsu","year":"2018","unstructured":"Hsu SH, Chen SH, Kuo CC, Chang JY. Ubiquitin-conjugating enzyme E2 B regulates the ubiquitination of O(6)-methylguanine-DNA methyltransferase and BCNU sensitivity in human nasopharyngeal carcinoma cells. Biochem Pharm. 2018;158:327\u201338.","journal-title":"Biochem Pharm"},{"key":"7969_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14711","volume":"30","author":"J Liu","year":"2024","unstructured":"Liu J, Wang K, Zhu Q, Zhang Y, Chen Y, Lou Z, et al. USP19 regulates DNA methylation damage repair and confers temozolomide resistance through MGMT stabilization. CNS Neurosci Ther. 2024;30:e14711.","journal-title":"CNS Neurosci Ther"},{"key":"7969_CR18","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1093\/carcin\/23.5.823","volume":"23","author":"M Xu-Welliver","year":"2002","unstructured":"Xu-Welliver M, Pegg AE. Degradation of the alkylated form of the DNA repair protein, O(6)-alkylguanine-DNA alkyltransferase. Carcinogenesis. 2002;23:823\u201330.","journal-title":"Carcinogenesis"},{"key":"7969_CR19","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3233\/CBM-210345","volume":"34","author":"X Li","year":"2022","unstructured":"Li X, Yang C, Luo N, Yang Y, Guo Y, Chen P, et al. Ubiquitination and degradation of MGMT by TRIM72 increases the sensitivity of uveal melanoma cells to Dacarbazine treatment. Cancer Biomark. 2022;34:275\u201384.","journal-title":"Cancer Biomark"},{"key":"7969_CR20","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/embor.2009.69","volume":"10","author":"GC Hassink","year":"2009","unstructured":"Hassink GC, Zhao B, Sompallae R, Altun M, Gastaldello S, Zinin NV, et al. The ER-resident ubiquitin-specific protease 19 participates in the UPR and rescues ERAD substrates. EMBO Rep. 2009;10:755\u201361.","journal-title":"EMBO Rep."},{"key":"7969_CR21","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1091\/mbc.E14-06-1129","volume":"26","author":"B Wiles","year":"2015","unstructured":"Wiles B, Miao M, Coyne E, Larose L, Cybulsky AV, Wing SS. USP19 deubiquitinating enzyme inhibits muscle cell differentiation by suppressing unfolded-protein response signaling. Mol Biol Cell. 2015;26:913\u201323.","journal-title":"Mol Biol Cell"},{"key":"7969_CR22","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41589-022-00971-2","volume":"18","author":"NJ Henning","year":"2022","unstructured":"Henning NJ, Boike L, Spradlin JN, Ward CC, Liu G, Zhang E, et al. Deubiquitinase-targeting chimeras for targeted protein stabilization. Nat Chem Biol. 2022;18:412\u201321.","journal-title":"Nat Chem Biol"},{"key":"7969_CR23","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.3892\/or.2016.5099","volume":"36","author":"L Yi","year":"2016","unstructured":"Yi L, Cui Y, Xu Q, Jiang Y. Stabilization of LSD1 by deubiquitinating enzyme USP7 promotes glioblastoma cell tumorigenesis and metastasis through suppression of the p53 signaling pathway. Oncol Rep. 2016;36:2935\u201345.","journal-title":"Oncol Rep."},{"key":"7969_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-1109-2","volume":"20","author":"W Zhang","year":"2020","unstructured":"Zhang W, Zhang J, Xu C, Zhang S, Bian S, Jiang F, et al. Ubiquitin-specific protease 7 is a drug-able target that promotes hepatocellular carcinoma and chemoresistance. Cancer Cell Int. 2020;20:28.","journal-title":"Cancer Cell Int"},{"key":"7969_CR25","doi-asserted-by":"publisher","first-page":"9228","DOI":"10.1111\/jcmm.16834","volume":"25","author":"M Xiang","year":"2021","unstructured":"Xiang M, Liang L, Kuang X, Xie Z, Liu J, Zhao S, et al. Pharmacological inhibition of USP7 suppresses growth and metastasis of melanoma cells in vitro and in vivo. J Cell Mol Med. 2021;25:9228\u201340.","journal-title":"J Cell Mol Med"},{"key":"7969_CR26","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nature737","volume":"416","author":"M Li","year":"2002","unstructured":"Li M, Chen D, Shiloh A, Luo J, Nikolaev AY, Qin J, et al. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature. 2002;416:648\u201353.","journal-title":"Nature"},{"key":"7969_CR27","doi-asserted-by":"publisher","first-page":"3921","DOI":"10.4161\/15384101.2014.973324","volume":"13","author":"I Alonso-de Vega","year":"2014","unstructured":"Alonso-de Vega I, Martin Y, Smits VA. USP7 controls Chk1 protein stability by direct deubiquitination. Cell Cycle. 2014;13:3921\u20136.","journal-title":"Cell Cycle"},{"key":"7969_CR28","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1093\/nar\/gks1359","volume":"41","author":"SV Khoronenkova","year":"2013","unstructured":"Khoronenkova SV, Dianov GL. USP7S-dependent inactivation of Mule regulates DNA damage signalling and repair. Nucleic Acids Res. 2013;41:1750\u20136.","journal-title":"Nucleic Acids Res"},{"key":"7969_CR29","doi-asserted-by":"publisher","first-page":"4280","DOI":"10.1172\/JCI120518","volume":"128","author":"D Su","year":"2018","unstructured":"Su D, Ma S, Shan L, Wang Y, Wang Y, Cao C, et al. Ubiquitin-specific protease 7 sustains DNA damage response and promotes cervical carcinogenesis. J Clin Invest. 2018;128:4280\u201396.","journal-title":"J Clin Invest"},{"key":"7969_CR30","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1080\/15384101.2015.1007785","volume":"14","author":"Q Zhu","year":"2015","unstructured":"Zhu Q, Sharma N, He J, Wani G, Wani AA. USP7 deubiquitinase promotes ubiquitin-dependent DNA damage signaling by stabilizing RNF168. Cell Cycle. 2015;14:1413\u201325.","journal-title":"Cell Cycle"},{"key":"7969_CR31","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/onc.2015.149","volume":"35","author":"A Zlatanou","year":"2016","unstructured":"Zlatanou A, Sabbioneda S, Miller ES, Greenwalt A, Aggathanggelou A, Maurice MM, et al. USP7 is essential for maintaining Rad18 stability and DNA damage tolerance. Oncogene. 2016;35:965\u201376.","journal-title":"Oncogene"},{"key":"7969_CR32","doi-asserted-by":"publisher","first-page":"13780","DOI":"10.3390\/ijms241813780","volume":"24","author":"C Le Clorennec","year":"2023","unstructured":"Le Clorennec C, Lee K, Huo Y, Zage PE. USP7 inhibition suppresses neuroblastoma growth via induction of p53-mediated apoptosis and EZH2 and N-Myc downregulation. International J Mol Sci. 2023;24:13780.","journal-title":"International J Mol Sci"},{"key":"7969_CR33","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1080\/15384101.2019.1695996","volume":"19","author":"Q Zhu","year":"2020","unstructured":"Zhu Q, Ding N, Wei S, Li P, Wani G, He J, et al. USP7-mediated deubiquitination differentially regulates CSB but not UVSSA upon UV radiation-induced DNA damage. Cell Cycle. 2020;19:124\u201341.","journal-title":"Cell Cycle"},{"key":"7969_CR34","doi-asserted-by":"publisher","first-page":"27278","DOI":"10.1074\/jbc.M114.589812","volume":"289","author":"J He","year":"2014","unstructured":"He J, Zhu Q, Wani G, Sharma N, Han C, Qian J, et al. Ubiquitin-specific protease 7 regulates nucleotide excision repair through deubiquitinating XPC protein and preventing XPC protein from undergoing ultraviolet light-induced and VCP\/p97 protein-regulated proteolysis. J Biol Chem. 2014;289:27278\u201389.","journal-title":"J Biol Chem"},{"key":"7969_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.561687","volume":"11","author":"N Fayyad","year":"2020","unstructured":"Fayyad N, Kobaisi F, Beal D, Mahfouf W, Ged C, Morice-Picard F, et al. Xeroderma pigmentosum C (XPC) mutations in primary fibroblasts impair base excision repair pathway and increase oxidative DNA damage. Front Genet. 2020;11:561687.","journal-title":"Front Genet"},{"key":"7969_CR36","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1089\/ars.2012.5036","volume":"18","author":"JP Melis","year":"2013","unstructured":"Melis JP, van Steeg H, Luijten M. Oxidative DNA damage and nucleotide excision repair. Antioxid Redox Signal. 2013;18:2409\u201319.","journal-title":"Antioxid Redox Signal"},{"key":"7969_CR37","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.15252\/embj.201490497","volume":"34","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Majid MC, Soll JM, Brickner JR, Dango S, Mosammaparast N. Noncanonical regulation of alkylation damage resistance by the OTUD4 deubiquitinase. EMBO J. 2015;34:1687\u2013703.","journal-title":"EMBO J"},{"key":"7969_CR38","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.molcel.2018.01.009","volume":"69","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Mudge MC, Soll JM, Rodrigues RB, Byrum AK, Schwarzkopf EA, et al. OTUD4 is a phospho-activated K63 deubiquitinase that regulates MyD88-dependent signaling. Mol Cell. 2018;69:505\u201316.","journal-title":"Mol Cell"},{"key":"7969_CR39","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1002\/cbic.201200261","volume":"13","author":"A Iph\u00f6fer","year":"2012","unstructured":"Iph\u00f6fer A, Kummer A, Nimtz M, Ritter A, Arnold T, Frank R, et al. Profiling ubiquitin linkage specificities of deubiquitinating enzymes with branched ubiquitin isopeptide probes. ChemBioChem. 2012;13:1416\u201320.","journal-title":"ChemBioChem"},{"key":"7969_CR40","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1093\/abbs\/gmab080","volume":"53","author":"Y Hou","year":"2021","unstructured":"Hou Y, Fan Y, Xia X, Pan J, Hou J, Liu X, et al. USP31 acetylation at Lys1264 is essential for its activity and cervical cancer cell growth. Acta Biochimica et Biophysica Sin. 2021;53:1037\u201343.","journal-title":"Acta Biochimica et Biophysica Sin"},{"key":"7969_CR41","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cellsig.2005.03.017","volume":"18","author":"C Tzimas","year":"2006","unstructured":"Tzimas C, Michailidou G, Arsenakis M, Kieff E, Mosialos G, Hatzivassiliou EG. Human ubiquitin specific protease 31 is a deubiquitinating enzyme implicated in activation of nuclear factor-\u03baB. Cellular Signal. 2006;18:83\u201392.","journal-title":"Cellular Signal"},{"key":"7969_CR42","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/ph6121475","volume":"6","author":"YP Ramirez","year":"2013","unstructured":"Ramirez YP, Weatherbee JL, Wheelhouse RT, Ross AH. Glioblastoma multiforme therapy and mechanisms of resistance. Pharmaceuticals (Basel). 2013;6:1475\u2013506.","journal-title":"Pharmaceuticals (Basel)"},{"key":"7969_CR43","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/carcin\/12.9.1739","volume":"12","author":"LE Ostrowski","year":"1991","unstructured":"Ostrowski LE, von Wronski MA, Bigner SH, Rasheed A, Schold SC Jr., Brent TP, et al. Expression of O6-methylguanine-DNA methyltransferase in malignant human glioma cell lines. Carcinogenesis. 1991;12:1739\u201344.","journal-title":"Carcinogenesis"},{"key":"7969_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-2-18","volume":"2","author":"H Mizuno","year":"2009","unstructured":"Mizuno H, Kitada K, Nakai K, Sarai A. PrognoScan: a new database for meta-analysis of the prognostic value of genes. BMC Med Genomics. 2009;2:18.","journal-title":"BMC Med Genomics"},{"key":"7969_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05373-4","volume":"9","author":"X Chen","year":"2018","unstructured":"Chen X, Zhang M, Gan H, Wang H, Lee JH, Fang D, et al. A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma. Nat Commun. 2018;9:2949.","journal-title":"Nat Commun"},{"key":"7969_CR46","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1007\/s00018-016-2255-5","volume":"73","author":"GL Grice","year":"2016","unstructured":"Grice GL, Nathan JA. The recognition of ubiquitinated proteins by the proteasome. Cell Mol Life Sci. 2016;73:3497\u2013506.","journal-title":"Cell Mol Life Sci"},{"key":"7969_CR47","doi-asserted-by":"publisher","first-page":"6073","DOI":"10.2147\/IJGM.S435030","volume":"16","author":"S-M Liu","year":"2023","unstructured":"Liu S-M, Zhao Q, Li W-J, Zhao J-Q. Advances in the study of MG53 in cardiovascular disease. International J Gen Med. 2023;16:6073\u201382.","journal-title":"International J Gen Med"},{"key":"7969_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.400","volume":"4","author":"YH Fan","year":"2013","unstructured":"Fan YH, Cheng J, Vasudevan SA, Dou J, Zhang H, Patel RH, et al. USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis. Cell Death Dis. 2013;4:e867.","journal-title":"Cell Death Dis"},{"key":"7969_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20259-0","volume":"12","author":"H Lei","year":"2021","unstructured":"Lei H, Xu HZ, Shan HZ, Liu M, Lu Y, Fang ZX, et al. Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stem\/progenitor cells in chronic myelogenous leukemia. Nat Commun. 2021;12:51.","journal-title":"Nat Commun"},{"key":"7969_CR50","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.biocel.2016.08.025","volume":"79","author":"C Zhang","year":"2016","unstructured":"Zhang C, Lu J, Zhang QW, Zhao W, Guo JH, Liu SL, et al. USP7 promotes cell proliferation through the stabilization of Ki-67 protein in non-small cell lung cancer cells. Int J Biochem Cell Biol. 2016;79:209\u201321.","journal-title":"Int J Biochem Cell Biol"},{"key":"7969_CR51","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.bmcl.2017.01.018","volume":"27","author":"C Chen","year":"2017","unstructured":"Chen C, Song J, Wang J, Xu C, Chen C, Gu W, et al. Synthesis and biological evaluation of thiazole derivatives as novel USP7 inhibitors. Bioorganic Med Chem Lett. 2017;27:845\u20139.","journal-title":"Bioorganic Med Chem Lett"},{"key":"7969_CR52","doi-asserted-by":"publisher","first-page":"31815","DOI":"10.18632\/oncotarget.16463","volume":"8","author":"F Morra","year":"2017","unstructured":"Morra F, Merolla F, Napolitano V, Ilardi G, Miro C, Paladino S, et al. The combined effect of USP7 inhibitors and PARP inhibitors in hormone-sensitive and castration-resistant prostate cancer cells. Oncotarget. 2017;8:31815\u201329.","journal-title":"Oncotarget"},{"key":"7969_CR53","doi-asserted-by":"publisher","first-page":"4546","DOI":"10.3390\/ijms22094546","volume":"22","author":"S Chen","year":"2021","unstructured":"Chen S, Liu Y, Zhou H. Advances in the development ubiquitin-specific peptidase (USP) inhibitors. Int J Mol Sci. 2021;22:4546.","journal-title":"Int J Mol Sci"},{"key":"7969_CR54","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.3390\/ijms25052768","volume":"25","author":"CH Lim","year":"2024","unstructured":"Lim CH, Fang XQ, Kang H, Oh T, Lee S, Kim YS, et al. ER stress-activated HSF1 governs cancer cell resistance to USP7 inhibitor-based chemotherapy through the PERK pathway. Int J Mol Sci. 2024;25:2768.","journal-title":"Int J Mol Sci"},{"key":"7969_CR55","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1158\/1535-7163.MCT-09-0097","volume":"8","author":"F Colland","year":"2009","unstructured":"Colland F, Formstecher E, Jacq X, Reverdy C, Planquette C, Conrath S, et al. Small-molecule inhibitor of USP7\/HAUSP ubiquitin protease stabilizes and activates p53 in cells. Mol Cancer Ther. 2009;8:2286\u201395.","journal-title":"Mol Cancer Ther"},{"key":"7969_CR56","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13046-024-02954-8","volume":"43","author":"J Li","year":"2024","unstructured":"Li J, Zhang B, Feng Z, An D, Zhou Z, Wan C, et al. Stabilization of KPNB1 by deubiquitinase USP7 promotes glioblastoma progression through the YBX1-NLGN3 axis. J Exp Clin Cancer Res. 2024;43:28.","journal-title":"J Exp Clin Cancer Res"},{"key":"7969_CR57","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/mt.2012.278","volume":"21","author":"T Viel","year":"2013","unstructured":"Viel T, Monfared P, Schelhaas S, Fricke IB, Kuhlmann MT, Fraefel C, et al. Optimizing glioblastoma temozolomide chemotherapy employing lentiviral-based anti-MGMT shRNA technology. Mol Ther. 2013;21:570\u20139.","journal-title":"Mol Ther"},{"key":"7969_CR58","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/biotech10020009","volume":"10","author":"E Maestri","year":"2021","unstructured":"Maestri E. The 3Rs principle in animal experimentation: a legal review of the state of the art in Europe and the case in Italy. BioTech (Basel). 2021;10:9.","journal-title":"BioTech (Basel)"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07969-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07969-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07969-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T10:05:22Z","timestamp":1757412322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07969-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7969"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07969-3","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"4 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures were performed in accordance with relevant guidelines and regulations and were approved by the Biomedical Research Ethics Committee of Hunan Normal University (Approval No. Lun Shen Ke 2024 (824)). The tissue microarray (TMA) used in this study was obtained from a commercial supplier (Zhongke Guanghua (Xi\u2019an, China) Intelligent Biotechnology Co., Ltd.), who confirmed that written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"631"}}